Mauna Kea Technologies SA announced a private placement of 11,911,852 common shares at a price of ?0.5037 per share for gross proceeds of ?6,000,000 on November 13, 2023. The transaction included participation from new investor Telix Pharmaceuticals Limited.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.91 AUD | +0.20% | +9.55% | +47.92% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
14.91 AUD | +0.20% | +9.55% | 3.21B | ||
0.39 EUR | +2.77% | 0.00% | 25.62M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.92% | 3.21B | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- TLX Stock
- News Telix Pharmaceuticals Limited
- Mauna Kea Technologies SA announced that it expects to receive ?6 million in funding from Telix Pharmaceuticals Limited